CILcare is a world’s leading R&D services company specialized in ear disorders. Based in Montpellier, Boston, and Paris, CILcare has become the one-stop partner for pharmaceutical industries, biotechs and medtechs developing novel therapies for people with hearing and otic disorders. If the importance of investigating tinnitus and hearing loss is pointed out, the underlying fundamental knowledge bases on animal models and the translational mindset are severely lacking. CILcare’s offer fills this gap by providing means to validate hypothesis towards solutions able to prevent and to reduce hearing disorders. CILcare designs and performs pharmacokinetics, efficacy, and GLP ototoxicity studies to assess drugs, medical devices, cell & gene therapies, on hearing loss, tinnitus, and otitis.
Click here for more information about CILcare